Experience of using advagraf after kidney transplantation in the Sklifosofsky Research Institute for Emergency Medicine
Abstract
The efficiency of the advagraf as the main immunosuppressant in renal transplant recipients in the early postoperative period has been assessed. A good tolerability of the medicament has been confirmed. Satisfactory performance of renal graft function recovery after surgery was marked. Recommendations on the use of the advagraf in the early terms after kidney transplantation, including a condition of a violation of the gastrointestinal tract function.
About the Authors
A. V. Pinchuk
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
B. V. Shmarin
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
R. V. Storojev
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
A. G. Balkarov
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
I. V. Dmitriev
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
E. M. Balakirev
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
Russian Federation
Russian Federation
References
1. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients; meta-analysis and meta-regression of randomized trail data / A.C. Webster, R.C. Woodroffe, R.S. Taylor [et al.] // Br. Med. J. – 2005. – Vol. 331. – P. 810–820.
2. Иммуносупрессия при трансплантации солидных органов / под ред. С. В. Готье. – М.: Триада, 2011. – С. 30–35.
3. Kramer, B.K. Better tolerability and significantly higher freedom from acute rejection at 7 years with tacrolimus vs cyclosporin-based immunosupression in renal transplant recipients / B.K Kramer // XLVII ERA-EDTA Congress-II DgfN Congress Munich, Germany, 2010, June25–28. – Munich, 2010. – Abst. OSu020.
4. Barratt, J. Immunosuppression for renal transplantation / J. Barratt, K. Harris, P. Topham // Oxford Desk Reference Nephrology / eds. J. Barratt, K. Harris, P. Topham. – Oxford: University press, 2009. – P. 563–564.
5. Хубутия, М.Ш. Трансплантация почки / М.Ш. Хубутия, А.В. Пинчук // Трансплантация органов и тканей в многопрофильном научном центре / под ред. М.Ш. Хубутия. – М.: АирАтр, 2011. – Гл.6. – С. 158–161.
6. Prograf and Advagraf Mix-up [Электронный ресурс] // ISMP Canada Safety Bulletin. – 2009. – Vol. 9, N 5. – Режим доступа: http://www.ismp-canada.org/download/safetyBulletins/ISMPCSB20095-PrografandAdvagrafMix-up.pdf
7. Improved adherence to tacrolimus oncedaily formulation in renal recipients: a randomized controlled trial using electronic monitoring / D.R.J. Kuypers, P.C. Peeters, J.J. Sennesael [et al.] // Transplantanion. – 2013. – Vol.95, N.2. – P. 333–340.
8. Conversion from prograf to extendedrelease tacrolimus in stable kidney transplant recipients: Better renal function after 3 year follow up / G. Spagnoletti, A. Gargiulo, E. Favi [et al.] // 16th Congress of the European Society for Organ Transplantation and using the Ecosystem.Vienna, 2013, 8–11 September. – Vienna, 2013. – Abst. ВО158.
9. Four-year experience with tacrolimus once-daily prolonged relase in patients from phase II conversion and de novo kidney, liver and heart studies / J.P. van Hooff, R.R. Alloway, P. Trunečka, M. Mourad // Clin. Transplant. – 2011. – Vol. 25, N. 1. – P.E 1–12.
10. Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stabil kidney transplant recipient – evaluation at 12 months / I. Shinichi, T. Tomohiro, N. Shingo [et al.] // 16th Congress of the European Society for Organ Transplantation and using the Ecosystem. Vienna, 2013, 8–11 September. – Vienna, 2013. – Abst. ВО189.
Review
For citations:
Pinchuk A.V., Shmarin B.V., Storojev R.V., Balkarov A.G., Dmitriev I.V., Balakirev E.M. Experience of using advagraf after kidney transplantation in the Sklifosofsky Research Institute for Emergency Medicine. Transplantologiya. The Russian Journal of Transplantation. 2013;(4):10-14. (In Russ.)
Views:
793
Email this article 